M&A Industry News

A collection of M&A latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

standard.co.uk - Henry Saker-Clark - AstraZeneca in talks over £300bn mega-merger with US rival - reports
AstraZeneca in talks over £300bn mega-merger with US rival - reports
Evening Standard

News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. AstraZeneca has held talks with US rival Bristol Myers…

independent.co.uk - Henry Saker-Clark - AstraZeneca in talks over £300bn mega-merger with US rival - reports
AstraZeneca in talks over £300bn mega-merger with US rival - reports
The Independent

AstraZeneca has held talks with US rival Bristol Myers Squibb over a merger which could create a drugs giant worth more than £300 billion, according to reports. The two pharmaceutical firms have held discussions over a potential tie-up in…

independent.co.uk - Henry Saker-Clark - AstraZeneca share prices drop amid £300bn mega-merger talks with US rival
AstraZeneca share prices drop amid £300bn mega-merger talks with US rival
The Independent

Reports suggest AstraZeneca has engaged in discussions with its US counterpart, Bristol Myers Squibb, regarding a potential merger that could establish a pharmaceutical behemoth valued at over £300 billion. The Financial Times indicated that…

standard.co.uk - Jeremy Cutler - Stocks mixed as AstraZeneca merger talk dents FTSE 100
Stocks mixed as AstraZeneca merger talk dents FTSE 100
Evening Standard

News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. The FTSE 100 underperformed European peers on Monday as…

theguardian.com - Julia Kollewe - AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
The Guardian

Britain's biggest drugmaker AstraZeneca is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by Pascal Soriot, its longtime…

theguardian.com - Nils Pratley - AstraZeneca should stick to its winning formula. It doesn't need a $400bn US mega-merger
AstraZeneca should stick to its winning formula. It doesn't need a $400bn US mega-merger
The Guardian

Sir Pascal Soriot, chief executive of AstraZeneca, starts with huge credit in the bank, obviously. His long tenure has been a triumph, starting with the against-the-odds victory over Pfizer's charmless accountants in 2014. The $39bn (£29bn)…

9to5mac.com - Ryan Christoffel - Apple's latest acquisition makes a lot of sense for product roadmap
Apple's latest acquisition makes a lot of sense for product roadmap
9to5Mac

Apple recently agreed to acquire a company called PlasmaSolve, according to EU-required filings. Here's why the new acquisition could make a lot of sense for Apple's future product roadmap. Apple is a secretive company that rarely discloses…

independent.co.uk - Jeremy Cutler - Stocks mixed as AstraZeneca merger talk dents FTSE 100
Stocks mixed as AstraZeneca merger talk dents FTSE 100
The Independent

The FTSE 100 underperformed European peers on Monday as heavy falls in AstraZeneca outweighed more optimistic noises in the Middle East. The FTSE 100 index closed down 10.35 points, 0.1%, at 10,857.70. The FTSE 250 ended up 249.75 points, 1.0%, at…

japantimes.co.jp - Takashi Nakamichi - Daiwa's profit hits 13-year high as equities business surges
Daiwa's profit hits 13-year high as equities business surges
The Japan Times

Daiwa Securities Group's latest quarterly profit rose more than analysts expected to the highest in 13 years, as Japan's second-largest brokerage benefited from a global stock trading boom. Net income rose 81% from a year earlier to ¥56.4…

investors.com - ALLISON GATLIN - AstraZeneca Stock Nosedives On Mega-Merger Rumor
AstraZeneca Stock Nosedives On Mega-Merger Rumor
Investor's Business Daily

AstraZeneca (AZN) stock took a nosedive Monday amid reports it's mulling a mega-merger with Bristol Myers Squibb (BMY). The combined company would be worth roughly $400 billion, 'making it one of the biggest pharmaceutical mergers in history,' RBC…

mirror.co.uk - Ethan Evans - Cosy living rooms' with B&M piece that can be 'extra seating
Cosy living rooms' with B&M piece that can be 'extra seating
Daily Mirror

Transform living rooms with an item that can double-up as 'extra seating' now on store shelves at B&M. The high street brand, which has over 500 stores nationwide, claims it can 'give spaces a cosy update'. B&M sells a wide range of affordable…

seekingalpha.com - SA Transcripts - Prysmian S.p.A. (PRYMY) M&A Call Transcript
Prysmian S.p.A. (PRYMY) M&A Call Transcript
Seeking Alpha

Prysmian S.p.A. (PRYMY) M&A Call August 3, 2026 4:00 AM EDT Massimo Battaini - Group CEO, GM & Executive Director Pier Facchini - CFO, CEO of Finance, Administration, Control & IT and Executive Director Max Yates - Morgan Stanley, Research Division…

bloomberg.com - Ashleigh Furlong - Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Why a Potential Astra-Bristol Merger Looks Like Pharma's FIFA Moment
Bloomberg

This article is for subscribers only. Hi, it's Ashleigh Furlong in London and Sonja Wind in Frankfurt, looking at the immediate reaction to news of a potential megamerger in the global pharmaceuticals industry. Also today, Italy's Prysmian extends…

wsj.com - AdriĆ  Calatayud - Banco BPM Pulls Out of Merger Talks With Monte Paschi
Banco BPM Pulls Out of Merger Talks With Monte Paschi
Wall Street Journal

Italian bank Banco BPM said it dropped out of talks to merge with peer, in a move that could clear the way for a rival $35 billion takeover offer from Intesa Sanpaolo. BPM said Friday that conditions for reaching an agreement with Monte dei Paschi…

vulture.com - Victoria Bekiempis - Hollywood's Hottest Fall Drama Is the Warnermount Merger
Hollywood's Hottest Fall Drama Is the Warnermount Merger
Vulture

On July 31, the legal battle over Paramount Skydance's planned $110 billion merger with Warner Bros. inched forward. Several state attorneys general who sued to stop this merger asked a California judge to schedule a trial for April. The request…

Receive a Daily briefing on M&A Industry News

Get Started